Host Responses in Tissue Repair and Fibrosis
- 24 January 2013
- journal article
- review article
- Published by Annual Reviews in Annual Review Of Pathology-Mechanisms Of Disease
- Vol. 8 (1), 241-276
- https://doi.org/10.1146/annurev-pathol-020712-163930
Abstract
Myofibroblasts accumulate in the spaces between organ structures and produce extracellular matrix (ECM) proteins, including collagen I. They are the primary “effector” cells in tissue remodeling and fibrosis. Previously, leukocyte progenitors termed fibrocytes and myofibroblasts generated from epithelial cells through epithelial-to-mesenchymal transition (EMT) were considered the primary sources of ECM-producing myofibroblasts in injured tissues. However, genetic fate mapping experiments suggest that mesenchyme-derived cells, known as resident fibroblasts, and pericytes are the primary precursors of scar-forming myofibroblasts, whereas epithelial cells, endothelial cells, and myeloid leukocytes contribute to fibrogenesis predominantly by producing key fibrogenic cytokines and by promoting cell-to-cell communication. Numerous cytokines derived from T cells, macrophages, and other myeloid cell populations are important drivers of myofibroblast differentiation. Monocyte-derived cell populations are key regulators of the fibrotic process: They act as a brake on the processes driving fibrogenesis, and they dismantle and degrade established fibrosis. We discuss the origins, modes of activation, and fate of myofibroblasts in various important fibrotic diseases and describe how manipulation of macrophage activation could help ameliorate fibrosis.Keywords
This publication has 163 references indexed in Scilit:
- Recent Developments in Myofibroblast Biology: Paradigms for Connective Tissue RemodelingThe American Journal of Pathology, 2012
- Hedgehog-Gli Pathway Activation during Kidney FibrosisThe American Journal of Pathology, 2012
- Relaxin Regulates Myofibroblast Contractility and Protects against Lung FibrosisThe American Journal of Pathology, 2011
- Migration of Fibrocytes in Fibrogenic Liver InjuryThe American Journal of Pathology, 2011
- Targeting Endothelium-Pericyte Cross Talk by Inhibiting VEGF Receptor Signaling Attenuates Kidney Microvascular Rarefaction and FibrosisThe American Journal of Pathology, 2011
- The origin of interstitial myofibroblasts in chronic kidney diseasePediatric Nephrology, 2011
- Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosisHepatology, 2011
- Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in miceHepatology, 2009
- The role of IL-1 in the pathogenesis of heart diseaseArchivum Immunologiae Et Therapiae Experimentalis, 2009
- Cellular and molecular mechanisms of fibrosisThe Journal of Pathology, 2007